Tilray Inc
TLRY
$3.27-2.68%
End of day · as of Oct 13, 2026, 8:00 PM ET
Mkt cap
$573.89M
EV/Sales
0.39
P/E ratio
N/A
FY2026 Revenue
$915.45M
EPS (9mo ended 2026-02-28)
$-0.65
Gross Margin (FY2026)
28.45%
Profit Margin (FY2026)
-13.26%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Use this TLRY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TLRY income, balance, and cash tables.
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Tilray Inc (TLRY) revenue for May 31, 2026 was $915.5M. Net income was -$121.4M. Statements: https://lician.com/financials/tlry
Tilray Inc (TLRY) market capitalization is $573.9M on the latest cached snapshot.
Tilray Inc (TLRY) cached previous close $3.36; day range $3.26 – $3.30; volume 4,052,442. Session quote: https://lician.com/quote/tlry
Tilray Inc (TLRY) latest cached earnings event is "TLRY earnings" on Oct 8, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TLRY filing is 8-K · Oct 8, 2026. Filings: https://lician.com/sec/tlry